Indtil nu er der ingen evidens for en øget risiko for medfødte abnormiteter eller andre bivirkninger, som følge af brugen af ciprofloxacin eller andre quinoloner, under 1. trimester.
Up to now, no evidence has been found of an increased risk of congenital abnormalities or other undesirable effects following use of ciprofloxacin or other quinolones during the first trimester.